Raltitrexed and pemetrexed studies in mesothelioma have not shown improved quality of life nor prolonged survival compared with effective pleurodesis with thoracoscopic talc poudrage
Gespeichert in:
Veröffentlicht in: | Journal of clinical oncology 2006-10, Vol.24 (28), p.4667; author reply 4667-4667 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4667 |
---|---|
container_issue | 28 |
container_start_page | 4667; author reply 4667 |
container_title | Journal of clinical oncology |
container_volume | 24 |
creator | Aelony, Yossef |
description | |
doi_str_mv | 10.1200/JCO.2006.08.0267 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68910016</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68910016</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-c54fc0e96dbaa7a0b99eef75dd585d5a4bcfc93b0a25344158289387c63280fd3</originalsourceid><addsrcrecordid>eNpFkUFv1DAQhS1ERZfCnRPyiVsWO45j54hWtIAqVapA4hY59rgxcuLUdrbtH-P34WhX4jSaeW-eNPMh9IGSPa0J-fzjcLcvtd0TuSd1K16hHeW1qITg_DXaEcHqikr2-xK9TekPIbSRjL9Bl1QQIgXpdujvvfLZ5QjPYLCaDV5ggnOb8mocJOxmPEEKeQTvwqTwqI6A55BxGsPTjN20xHAs_sdVeZdfcLDYO7tZIi6SD_PDlrbGozsqj3WYFhXL5MnlEYO1oLMriYuHNQYDyaWTlMcQlQ5Jh8VpnJXXeAmrieoB3qELq3yC9-d6hX5df_15-Fbd3t18P3y5rTRjXa40b6wm0LVmUEooMnQdgBXcGC654aoZtNUdG4iqOWsaymUtOyaFblktiTXsCn065ZY7HldIuZ9c0uC9miGsqW9lR8tb22IkJ6OOIaUItl-im1R86SnpN1Z9YdVvrHoi-41VWfl4zl6HCcz_hTMc9g8psJYw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68910016</pqid></control><display><type>article</type><title>Raltitrexed and pemetrexed studies in mesothelioma have not shown improved quality of life nor prolonged survival compared with effective pleurodesis with thoracoscopic talc poudrage</title><source>MEDLINE</source><source>American Society of Clinical Oncology Online Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Aelony, Yossef</creator><creatorcontrib>Aelony, Yossef</creatorcontrib><identifier>ISSN: 0732-183X</identifier><identifier>EISSN: 1527-7755</identifier><identifier>DOI: 10.1200/JCO.2006.08.0267</identifier><identifier>PMID: 17008709</identifier><language>eng</language><publisher>United States</publisher><subject>Cisplatin - therapeutic use ; Clinical Trials as Topic ; Glutamates - therapeutic use ; Guanine - analogs & derivatives ; Guanine - therapeutic use ; Humans ; Mesothelioma - complications ; Mesothelioma - drug therapy ; Pemetrexed ; Pleural Neoplasms - complications ; Pleural Neoplasms - drug therapy ; Pleurodesis - methods ; Quality of Life ; Quinazolines - therapeutic use ; Talc ; Thiophenes - therapeutic use ; Treatment Outcome</subject><ispartof>Journal of clinical oncology, 2006-10, Vol.24 (28), p.4667; author reply 4667-4667</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-c54fc0e96dbaa7a0b99eef75dd585d5a4bcfc93b0a25344158289387c63280fd3</citedby><cites>FETCH-LOGICAL-c339t-c54fc0e96dbaa7a0b99eef75dd585d5a4bcfc93b0a25344158289387c63280fd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3729,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17008709$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aelony, Yossef</creatorcontrib><title>Raltitrexed and pemetrexed studies in mesothelioma have not shown improved quality of life nor prolonged survival compared with effective pleurodesis with thoracoscopic talc poudrage</title><title>Journal of clinical oncology</title><addtitle>J Clin Oncol</addtitle><subject>Cisplatin - therapeutic use</subject><subject>Clinical Trials as Topic</subject><subject>Glutamates - therapeutic use</subject><subject>Guanine - analogs & derivatives</subject><subject>Guanine - therapeutic use</subject><subject>Humans</subject><subject>Mesothelioma - complications</subject><subject>Mesothelioma - drug therapy</subject><subject>Pemetrexed</subject><subject>Pleural Neoplasms - complications</subject><subject>Pleural Neoplasms - drug therapy</subject><subject>Pleurodesis - methods</subject><subject>Quality of Life</subject><subject>Quinazolines - therapeutic use</subject><subject>Talc</subject><subject>Thiophenes - therapeutic use</subject><subject>Treatment Outcome</subject><issn>0732-183X</issn><issn>1527-7755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkUFv1DAQhS1ERZfCnRPyiVsWO45j54hWtIAqVapA4hY59rgxcuLUdrbtH-P34WhX4jSaeW-eNPMh9IGSPa0J-fzjcLcvtd0TuSd1K16hHeW1qITg_DXaEcHqikr2-xK9TekPIbSRjL9Bl1QQIgXpdujvvfLZ5QjPYLCaDV5ggnOb8mocJOxmPEEKeQTvwqTwqI6A55BxGsPTjN20xHAs_sdVeZdfcLDYO7tZIi6SD_PDlrbGozsqj3WYFhXL5MnlEYO1oLMriYuHNQYDyaWTlMcQlQ5Jh8VpnJXXeAmrieoB3qELq3yC9-d6hX5df_15-Fbd3t18P3y5rTRjXa40b6wm0LVmUEooMnQdgBXcGC654aoZtNUdG4iqOWsaymUtOyaFblktiTXsCn065ZY7HldIuZ9c0uC9miGsqW9lR8tb22IkJ6OOIaUItl-im1R86SnpN1Z9YdVvrHoi-41VWfl4zl6HCcz_hTMc9g8psJYw</recordid><startdate>20061001</startdate><enddate>20061001</enddate><creator>Aelony, Yossef</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20061001</creationdate><title>Raltitrexed and pemetrexed studies in mesothelioma have not shown improved quality of life nor prolonged survival compared with effective pleurodesis with thoracoscopic talc poudrage</title><author>Aelony, Yossef</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-c54fc0e96dbaa7a0b99eef75dd585d5a4bcfc93b0a25344158289387c63280fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Cisplatin - therapeutic use</topic><topic>Clinical Trials as Topic</topic><topic>Glutamates - therapeutic use</topic><topic>Guanine - analogs & derivatives</topic><topic>Guanine - therapeutic use</topic><topic>Humans</topic><topic>Mesothelioma - complications</topic><topic>Mesothelioma - drug therapy</topic><topic>Pemetrexed</topic><topic>Pleural Neoplasms - complications</topic><topic>Pleural Neoplasms - drug therapy</topic><topic>Pleurodesis - methods</topic><topic>Quality of Life</topic><topic>Quinazolines - therapeutic use</topic><topic>Talc</topic><topic>Thiophenes - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aelony, Yossef</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aelony, Yossef</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Raltitrexed and pemetrexed studies in mesothelioma have not shown improved quality of life nor prolonged survival compared with effective pleurodesis with thoracoscopic talc poudrage</atitle><jtitle>Journal of clinical oncology</jtitle><addtitle>J Clin Oncol</addtitle><date>2006-10-01</date><risdate>2006</risdate><volume>24</volume><issue>28</issue><spage>4667; author reply 4667</spage><epage>4667</epage><pages>4667; author reply 4667-4667</pages><issn>0732-183X</issn><eissn>1527-7755</eissn><cop>United States</cop><pmid>17008709</pmid><doi>10.1200/JCO.2006.08.0267</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0732-183X |
ispartof | Journal of clinical oncology, 2006-10, Vol.24 (28), p.4667; author reply 4667-4667 |
issn | 0732-183X 1527-7755 |
language | eng |
recordid | cdi_proquest_miscellaneous_68910016 |
source | MEDLINE; American Society of Clinical Oncology Online Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Cisplatin - therapeutic use Clinical Trials as Topic Glutamates - therapeutic use Guanine - analogs & derivatives Guanine - therapeutic use Humans Mesothelioma - complications Mesothelioma - drug therapy Pemetrexed Pleural Neoplasms - complications Pleural Neoplasms - drug therapy Pleurodesis - methods Quality of Life Quinazolines - therapeutic use Talc Thiophenes - therapeutic use Treatment Outcome |
title | Raltitrexed and pemetrexed studies in mesothelioma have not shown improved quality of life nor prolonged survival compared with effective pleurodesis with thoracoscopic talc poudrage |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T08%3A30%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Raltitrexed%20and%20pemetrexed%20studies%20in%20mesothelioma%20have%20not%20shown%20improved%20quality%20of%20life%20nor%20prolonged%20survival%20compared%20with%20effective%20pleurodesis%20with%20thoracoscopic%20talc%20poudrage&rft.jtitle=Journal%20of%20clinical%20oncology&rft.au=Aelony,%20Yossef&rft.date=2006-10-01&rft.volume=24&rft.issue=28&rft.spage=4667;%20author%20reply%204667&rft.epage=4667&rft.pages=4667;%20author%20reply%204667-4667&rft.issn=0732-183X&rft.eissn=1527-7755&rft_id=info:doi/10.1200/JCO.2006.08.0267&rft_dat=%3Cproquest_cross%3E68910016%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68910016&rft_id=info:pmid/17008709&rfr_iscdi=true |